1 / 6
Laboratory Research Material
PE-22-28
10 mg per vial · Lyophilized powder
Laboratory Research Material
PE-22-28 10 mg per vial
$59
- Compound
- PE-22-28
- Amount per vial
- 10 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- 2 business daysEstimated transitFree
shipping On orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
PE-22-28 10 mg
Buy PE-22-28 10 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
PE-22-28 is a shortened, seven-residue spadin-related peptide studied as an inhibitor of the TREK-1 potassium channel.
Match the peptide to your method
PE-22-28, full-length spadin and terminally modified PE-22-28 analogs are distinct research materials. Match the sequence and terminal chemistry used in your reference method before selecting specifications or making preparation calculations.
The original shortened-spadin study compared the parent sequence with peptides carrying end-group changes or an amino-acid substitution. Some modifications retained channel inhibition; others did not. A shared name fragment therefore does not establish equivalent activity.
The 10 mg amount is the package label, not an assay concentration. The 3 mL figure describes vial capacity; the supplied material is powder, not 3 mL of prepared solution.
TREK-1 research context
In the same 2017 study, researchers used whole-cell patch-clamp recordings in HEK cells expressing human TREK-1. They measured changes in channel current and compared PE-22-28 with spadin and modified analogs. Testing against several other potassium channels helped assess specificity under those experimental conditions.
The work also measured behavior in mice, including immobility in the forced swim test and feeding latency in another test. These endpoints address different questions from channel-current measurements. They do not establish a clinical outcome or demonstrate how this commercial preparation will perform in a different assay.
Product documents and analytical checks
Open Documents to review the files currently available for this item. Where a batch report is available, match its product identity and lot before using its results. A general product file and a lot-specific analytical report serve different purposes.
Review identity, chromatographic purity and measured content as separate properties. For chemical calculations, confirm the supplied form rather than borrowing an acetate or other salt specification from another supplier. Storage and prepared-solution conditions should likewise follow evidence for the actual material and the requirements of your laboratory method.
Additional information
| CAS No. | 1801959-12-5 |
|---|---|
| Purity | ≥99% |
| Sequence | GVSWGLR |
| Molecular Formula | C35H55N11O9 |
| Molecular Weight | 773.89 g/mol |
| Applications | Depression models, neurogenesis studies, stroke recovery, TREK-1 inhibition |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
COA & Documents
Independent lot testing
PE-22-28 10mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 77826
- Report number
- COA12531
- Date tested
- November 12, 2026
- Reported purity
- 99.85%
- Labeled content
- 10 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for PE-22-28 10mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.

shipping